{
 "drug": "Cefotaxime Sodium Powder, for Solution",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "02/17/2015",
 "dayN": 4207,
 "cat": "Anti-Infective",
 "companies": [
  "Hikma Pharmaceuticals USA, Inc.",
  "SteriMax, Inc."
 ],
 "reasons": [
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2015",
   "package_ndc": "0143-9931-25",
   "generic_name": "Cefotaxime Sodium Powder, for Solution",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA065072"
    ],
    "brand_name": [
     "CEFOTAXIME"
    ],
    "generic_name": [
     "CEFOTAXIME"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9931",
     "0143-9933",
     "0143-9930"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFOTAXIME SODIUM"
    ],
    "rxcui": [
     "309068",
     "1656313",
     "1656318"
    ],
    "spl_id": [
     "7e0897ec-2275-4438-9cc5-4c951e52ad97"
    ],
    "spl_set_id": [
     "ed23b6bc-32c7-4c50-a53d-313ae78e5623"
    ],
    "package_ndc": [
     "0143-9931-01",
     "0143-9931-25",
     "0143-9933-01",
     "0143-9933-25",
     "0143-9930-01",
     "0143-9930-10"
    ],
    "unii": [
     "258J72S7TZ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Pediatric"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2015",
   "package_ndc": "0143-9933-25",
   "generic_name": "Cefotaxime Sodium Powder, for Solution",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA065072"
    ],
    "brand_name": [
     "CEFOTAXIME"
    ],
    "generic_name": [
     "CEFOTAXIME"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9933",
     "0143-9931",
     "0143-9930"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFOTAXIME SODIUM"
    ],
    "rxcui": [
     "309068",
     "1656313",
     "1656318"
    ],
    "spl_id": [
     "7e0897ec-2275-4438-9cc5-4c951e52ad97"
    ],
    "spl_set_id": [
     "ed23b6bc-32c7-4c50-a53d-313ae78e5623"
    ],
    "package_ndc": [
     "0143-9931-01",
     "0143-9931-25",
     "0143-9933-01",
     "0143-9933-25",
     "0143-9930-01",
     "0143-9930-10"
    ],
    "unii": [
     "258J72S7TZ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Pediatric"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2015",
   "package_ndc": "0143-9935-01",
   "generic_name": "Cefotaxime Sodium Powder, for Solution",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA065071"
    ],
    "brand_name": [
     "CEFOTAXIME"
    ],
    "generic_name": [
     "CEFOTAXIME"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9935"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFOTAXIME SODIUM"
    ],
    "rxcui": [
     "309065"
    ],
    "spl_id": [
     "e25af43f-54cb-4526-a8a5-6bef0a7939c7"
    ],
    "spl_set_id": [
     "ef1a6dc6-bc3d-4f09-8f92-7ff328f56561"
    ],
    "package_ndc": [
     "0143-9935-01"
    ],
    "unii": [
     "258J72S7TZ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Pediatric"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/17/2015",
   "package_ndc": "21586-012-02",
   "generic_name": "Cefotaxime Sodium Powder, for Solution",
   "related_info_link": "https://www.fda.gov/media/193116/download?attachment",
   "contact_info": "800-881-3550",
   "availability": "Available",
   "openfda": {
    "brand_name": [
     "CEFOTAXIME"
    ],
    "generic_name": [
     "CEFOTAXIME INJECTION"
    ],
    "manufacturer_name": [
     "SteriMax Inc."
    ],
    "product_ndc": [
     "21586-012",
     "21586-011"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFOTAXIME SODIUM"
    ],
    "rxcui": [
     "1656313",
     "1656318"
    ],
    "spl_id": [
     "7a77a18a-3d8c-4bac-8d21-54a88db396f6"
    ],
    "spl_set_id": [
     "8efe3bd0-c43a-2bd6-e053-2a95a90a92fa"
    ],
    "package_ndc": [
     "21586-011-01",
     "21586-011-02",
     "21586-012-01",
     "21586-012-02"
    ],
    "unii": [
     "258J72S7TZ"
    ]
   },
   "update_date": "06/15/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Pediatric"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)",
   "company_name": "SteriMax, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/17/2015",
   "package_ndc": "0143-9930-10",
   "generic_name": "Cefotaxime Sodium Powder, for Solution",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA065072"
    ],
    "brand_name": [
     "CEFOTAXIME"
    ],
    "generic_name": [
     "CEFOTAXIME"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9930",
     "0143-9931",
     "0143-9933"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFOTAXIME SODIUM"
    ],
    "rxcui": [
     "309068",
     "1656313",
     "1656318"
    ],
    "spl_id": [
     "7e0897ec-2275-4438-9cc5-4c951e52ad97"
    ],
    "spl_set_id": [
     "ed23b6bc-32c7-4c50-a53d-313ae78e5623"
    ],
    "package_ndc": [
     "0143-9931-01",
     "0143-9931-25",
     "0143-9933-01",
     "0143-9933-25",
     "0143-9930-01",
     "0143-9930-10"
    ],
    "unii": [
     "258J72S7TZ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Pediatric"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/17/2015",
   "package_ndc": "21586-011-02",
   "generic_name": "Cefotaxime Sodium Powder, for Solution",
   "related_info_link": "https://www.fda.gov/media/193116/download?attachment",
   "contact_info": "800-881-3550",
   "availability": "Available",
   "openfda": {
    "brand_name": [
     "CEFOTAXIME"
    ],
    "generic_name": [
     "CEFOTAXIME INJECTION"
    ],
    "manufacturer_name": [
     "SteriMax Inc."
    ],
    "product_ndc": [
     "21586-011",
     "21586-012"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFOTAXIME SODIUM"
    ],
    "rxcui": [
     "1656313",
     "1656318"
    ],
    "spl_id": [
     "7a77a18a-3d8c-4bac-8d21-54a88db396f6"
    ],
    "spl_set_id": [
     "8efe3bd0-c43a-2bd6-e053-2a95a90a92fa"
    ],
    "package_ndc": [
     "21586-011-01",
     "21586-011-02",
     "21586-012-01",
     "21586-012-02"
    ],
    "unii": [
     "258J72S7TZ"
    ]
   },
   "update_date": "06/15/2026",
   "therapeutic_category": [
    "Anti-Infective",
    "Pediatric"
   ],
   "dosage_form": "Powder, For Solution",
   "presentation": "Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)",
   "company_name": "SteriMax, Inc.",
   "status": "Current"
  }
 ]
}